Delivery Order SPE2DB24D2205-SPE2DB25FEFPG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imbruvica 70 mg capsules (28-count units) with a contract value of $7,575.75. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award was made through open competition with no set-aside designation, and the place of performance is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (quantity 28) under a firm fixed-price contract. The order, valued at $7,575.75, was competitively awarded without a set-aside designation and is scheduled for completion by August 8, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count packaging) under a firm fixed price contract type. The delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,575.75 to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 mg tablets (28-count units) with delivery to Conshohocken, Pennsylvania. This contract, awarded on August 4, 2025, utilizes a firm fixed-price structure with an ultimate completion date of August 25, 2025. The award was made without a set-aside designation, indicating it was competitively awarded among qualified vendors. This delivery order represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $15,151.52 on July 24, 2025, for the supply of Imbruvica 280 mg tablets (28-count packaging) to support federal medical procurement needs. The contract carries a firm fixed price structure and is not set aside for any particular business category. Performance is scheduled for completion by August 14, 2025, with work being conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a $33,865.10 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,188,793 units of the drug Imbruvica 420 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through May 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $15,151.52 for IMBRUVICA 280mg 28-count tablets under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The award, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a $14,645.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imbruvica 420 mg tablets. The order has an ultimate completion date of September 17, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of pharmaceutical products and medical supplies to support military treatment...
- This delivery order, valued at $15,151.52, awards AmerisourceBergen Drug Corp the supply of IMBRUVICA 420 mg tablets (28-count units) under a competitive, non-set-aside procurement by the Defense Logistics Agency (DLA). The contract carries a firm fixed price structure with an ultimate completion date of August 11, 2025, and fulfillment will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFPGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imbruvica 140 mg tablets (28-count) at a ceiling value of $7,575.75. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 20, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a pediatric formulation of a critical oncology medication used in the treatment of certain blood cancers, supporting the federal government's pharmaceutical supply chain for military and defense healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp has demonstrated the capability to supply an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide through competitive, open-market contracting.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 7/30/25 |